Mood Disorders Bladder Cancer

Study Overview
=================
Brief Summary
-----------------
This is a cross-sectional study evaluating mood disorders in bladder cancer patients and their caregivers across the bladder cancer trajectory

Official Title
-----------------
Evaluation of Mood Disorders in Bladder Cancer Patients and Their Primary Caregivers

Conditions
-----------------
Bladder Cancer

Intervention / Treatment
-----------------
* Other: Mood Disorder Assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients or caregiver of patient with a histologic diagnosis of bladder cancer of the following subtypes, urothelial carcinoma, adenocarcinoma, or squamous cell carcinoma, within 24 months of survey administration and received treatment at the University of Kansas Health System ≥ 18 years of age Have a patient-designated primary informal/family caregiver Able to speak and read English Willing and able to provide informed consent Functioning telephone number or access to one Exclusion Criteria: Patients or caregivers of patients with metastatic bladder cancer Patients who are unable to designate a primary caregiver Patients and caregivers who do not both consent to study participation

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Mood Disorder Assessment|Assess depression, anxiety, HRQOL, and financial toxicity in both bladder cancer patients and their caregivers via telephone survey|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Severity of depression in bladder cancer patients and their caregivers: Patient-Health Questionnaire-9 | Assessed using Patient-Health Questionnaire-9. A standard questionnaire with 9 questions. Score 5-9 is minimal symptoms, 10-14 is minor depression, 15-19 is major depression moderately severe, and 20-27 is severe major depression. | Data will be assessed through study completion, on average one year | 
| Severity of anxiety in bladder cancer patients and their caregivers: Generalized Anxiety Disorder-7 | Assessed using Generalized Anxiety Disorder-7. A standard questionnaire composed of seven questions with scores ranging from 0 to 21. A score between 5 and 9 indicates mild anxiety, a score between 10 and 14 indicates moderate anxiety, and a score 15 or above indicates severe anxiety. | Data will be assessed through study completion, on average one year | 
| Health-related quality of life in bladder cancer patients and their caregivers: Short Form-12 | Assessed using Short Form-12. A standard questionnaire with twelve questions, with a score from 0 to 100, where a zero indicates lowest level of health and 100 indicates highest level of health. | Data will be assessed through study completion, on average one year | 
| Financial Toxicity in bladder cancer patients and their caregivers | Assessed using single-item financial toxicity measure. The measure asks patients to indicate number that best describes their financial stress during pass week from a scale of 0 to 10 with 0 indicating no financial distress and 10 indicating extreme financial distress | Data will be assessed through study completion, on average one year |